Navigation Links
Organize Your Data from the Big Blue Mutation Assay


Record, analyze, and report data with the MutaTrak electronic notebook

G. (Paul) Kotturi Mark J. Dycaico
Stratagene

Marc Hamovitch Doug Schroeder
Solana Consulting Group, Solana Beach, CA

Stratagene introduces the MutaTrak electronic notebook to record Big Blue transgenic rodent mutation assay * data in an electronic format. Data are entered in a logical order and updated easily as an experiment continues. After experiments are completed, analysis and reporting features greatly simplify data interpretation and manuscript preparation.

Stratagenes new MutaTrak electronic notebook creates a convenient and comprehensive user interface with the Big Blue mutation assay.1 Scientists using the Big Blue system have specially designed the MutaTrak electronic notebook, resulting in an efficient and thorough software package featuring data entry, online documentation, data analysis, and report generation capabilities.

The MutaTrak electronic notebook runs on the Windows 95 platform, either as a stand-alone application or in a multiuser network environment. Information is organized in a hierarchical database structure. An administration system is used to set up user profiles in which security privileges (blocked access, read-only access, or read/write access) may be assigned for each data-entry section. Detailed experimental notes can be entered at each level, allowing users to store specific information. Additional features include online help, password security, and utilities.

Data Entry

Figure 1

As shown in Figure 1, data entry is arranged using the popular and simple recipe card design, which facilitates data entry and retrieval. The card tabs are always visible; the highlighted tab in dicates the active section. Just click on the tabs and flip through the recipe cards from left to right as information is entered. Location in the data hierarchy is constantly displayed in the guide boxes at the bottom of the screen. These guide boxes are automatically updated as new information is entered. In addition to monitoring hierarchical position, they can also be used to quickly jump to other areas in the data structure by making a selection from the dropdown list in each box. In this way, the accuracy of the data entered lower in the hierarchy can be checked.

The MutaTrak electronic notebook can be used with both the established lacI plaque color-screening method2 and the l Select-cII mutation assay kit3. Once the screening method is chosen, the corresponding fields specific to the particular assay are presented. On the Screening page, mutant information is entered. After DNA sequence information is available, the specific mutation(s) identified for each mutant can be cataloged and categorized in detail (Figure 2).

Figure 2

Reporting

When data entry is complete, a range of reporting tools is available: Using the Mutant Frequency Report, data are collated from separate plating experiments, and mutant frequencies are calculated. The report compares mutant frequencies from two treatment groups. Mutational events are assessed using the Mutational Spectrum Report, which tabulates mutational spectra based on the occurrence of each mutation type. Specialized computations are also performed, such as calculating the percentage of mutations at CpG sites and correcting for possible clonal effects. In addition to the standard re ports, an ad-hoc reporting feature enables users to create customized lists of up to seven simultaneously displayed fields. Customized formats can be saved for later use. Ad-hoc reports can also be exported in a database format (*.xls) for further analysis or formatting using a standard spreadsheet application.

Conclusions

The MutaTrak Electronic Notebook provides data storage and analysis in an easy-to-use system that encompasses both the lacI plaque color screening and the l Select-cII mutation assays. With the MutaTrak electronic notebook, all experimental details are organized in one format and one place; hence, data can be quickly and easily interpreted, reported, and maintained.

REFERENCES
  1. Kohler, S.W., et al. (1991) Proc. Natl. Acad. Sci. U.S.A. 88: 7958-7962.

  2. Kohler, S.W., et al. (1991) Environ. Mol. Mutagen. 18: 316-321.

  3. Jakubczak, J.L., et al. (1996) Proc. Natl. Acad. Sci. U.S.A. 93: 9073-9078.

* U.S. Patent Nos. 5,347,075 and 5,589,155; European Patent No. 0289121; Japanese Patent No. 2618973


'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. A Positive Selection Assay for Mutation Analysis in Big Blue Animals
2. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
3. Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer
4. Mutation detection for the K- rasand P16 genes
5. A Multiple Mutation Model System as a Test Development and Training Tool for Denaturing Gradient Gel Electrophoresis
6. Detection of K-ras Point Mutations in the Pancreas by Constant Denaturing Gel Electrophoresis Using the DCode System
7. Detection of Mutations in the Fas Antigen of Lymphoma Tumors by RT-PCR and Denaturing Gradient Gel Electrophoresis
8. Identification of Disease Causing Mutations in Phenylketonuria by Denaturing Gradient Gel Electrophoresis Using the DCode System
9. Temporal Temperature Gradient Electrophoresis: A Powerful Technique to Screen Mutations
10. Detection of Mutations in the CYP21 Gene Using the DCode System
11. Rapid, High Throughput Mutation Discovery Using Fluorescent SSCP on the ABI PRISM 3100 and 3100Avant Genetic Analyzers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... San Diego, CA (PRWEB) , ... May 26, ... ... assay development and manufacturing company, today announced several positive developments that position the ... As a result of the transaction, Craig F. Kinghorn has been appointed ...
(Date:5/25/2016)... ... May 25, 2016 , ... Founder of the Fitzmaurice Hand ... and surgery of the hand by the National Board of Physicians and Surgeons, ... and beyond in his pursuit of providing the most comprehensive, effective treatment for ...
(Date:5/25/2016)... ... May 25, 2016 , ... Biohaven Pharmaceutical Holding Company ... granted the company’s orphan drug designation request covering BHV-4157 for the treatment of ... the FDA. , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder that ...
(Date:5/23/2016)... ... May 23, 2016 , ... The need for blood donations in South Texas and across ... South Texas Blood & Tissue Center, blood donations are on the decline. In fact, donations ... are down 21 percent in South Texas in the last four years alone. , There ...
Breaking Biology Technology:
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
Breaking Biology News(10 mins):